BioCryst Pitches Peramivir In Emerging Markets

BioCryst Pharmaceuticals is following one of BMI's core views for the pharmaceuticals and healthcare industry. The Alabama-based drugmaker has signed deals with three companies to promote its investigational influenza drug in emerging markets, which we believe will drive industry growth.

To read the full article, please choose one of the following options: